Christopher T. Giordano
2023
In 2023, Christopher T. Giordano earned a total compensation of $644.8K as President and Chief Executive Officer at Tenax Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,650 |
|---|---|
| Salary | $405,300 |
| Other | $36,820 |
| Total | $644,770 |
Giordano received $405.3K in salary, accounting for 63% of the total pay in 2023.
Giordano also received $202.7K in non-equity incentive plan and $36.8K in other compensation.
Rankings
In 2023, Christopher T. Giordano's compensation ranked 1,495th out of 2,311 executives tracked by ExecPay. In other words, Giordano earned more than 35.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,495 out of 2,311 | 35th |
Division Manufacturing | 859 out of 1,247 | 31st |
Major group Chemicals And Allied Products | 541 out of 705 | 23rd |
Industry group Drugs | 527 out of 676 | 22nd |
Industry Pharmaceutical Preparations | 379 out of 490 | 23rd |
Source: SEC filing on April 26, 2024.
Giordano's colleagues
We found two more compensation records of executives who worked with Christopher T. Giordano at Tenax Therapeutics in 2023.